Therefore, it is reasonable to postulate that CD44 and STAT3 not only mediate CAF-driven ovarian tumor stemness and chemoresistance within tumor cells, but also cooperate within CAFs themselves to support their cancer-promoting phenotype, which requires further investigation. The gene discussed is CD44; the disease is cancer.